|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTIANS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF AETHOLON MEDICAL, INC. FOR THE THREE MONTHS
ENDED JUNE 30, 2000
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 22,878
<SECURITIES> 0
<RECEIVABLES> 69,011
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 131,037
<PP&E> 168,241
<DEPRECIATION> 130,354
<TOTAL-ASSETS> 2,332,340
<CURRENT-LIABILITIES> 2,420,605
<BONDS> 0
0
0
<COMMON> 2,772
<OTHER-SE> (91,037)
<TOTAL-LIABILITY-AND-EQUITY> 2,332,340
<SALES> 0
<TOTAL-REVENUES> 21,321
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 332,907
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 314,198
<INCOME-PRETAX> (625,784)
<INCOME-TAX> 659
<INCOME-CONTINUING> (626,443)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (626,443)
<EPS-BASIC> (0.23)
<EPS-DILUTED> (0.23)
</TABLE>
|
|